|
|
Volumn 70, Issue 3, 2015, Pages 297-298
|
|
A UK-based resource to support the monitoring and safe use of anti-TB drugs and second-line treatment of multidrug-resistant TB
a,f
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AMIKACIN;
AMINOSALICYLIC ACID;
AMOXICILLIN PLUS CLAVULANIC ACID;
BEDAQUILINE;
CAPREOMYCIN;
CILASTATIN PLUS IMIPENEM;
CLARITHROMYCIN;
CLOFAZIMINE;
CYCLOSERINE;
ETHAMBUTOL;
ISONIAZID;
LEVOFLOXACIN;
LINEZOLID;
MEROPENEM;
MOXIFLOXACIN;
OFLOXACIN;
PROTIONAMIDE;
PYRAZINAMIDE;
RIFABUTIN;
RIFAMPICIN;
STREPTOMYCIN;
THIOACETAZONE;
TUBERCULOSTATIC AGENT;
ACCESS TO INFORMATION;
CONSENSUS DEVELOPMENT;
DRUG SAFETY;
DRUG SURVEILLANCE PROGRAM;
DRUG USE;
HUMAN;
INTERNET;
MEDICAL AUDIT;
MEDICAL RESEARCH;
MEDICAL SOCIETY;
MULTIDRUG RESISTANT TUBERCULOSIS;
PRACTICE GUIDELINE;
PRIORITY JOURNAL;
REVIEW;
UNITED KINGDOM;
GREAT BRITAIN;
TUBERCULOSIS, MULTIDRUG-RESISTANT;
TUBERCULOSIS, PULMONARY;
ANTITUBERCULAR AGENTS;
GREAT BRITAIN;
HUMANS;
PRACTICE GUIDELINES AS TOPIC;
TUBERCULOSIS, MULTIDRUG-RESISTANT;
TUBERCULOSIS, PULMONARY;
|
|
EID: 84923193231
PISSN: 00406376
EISSN: 14683296
Source Type: Journal
DOI: 10.1136/thoraxjnl-2014-205278 Document Type: Review |
|
Times cited : (9)
|
|
References (5)
|
